| __timestamp | Alkermes plc | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 447875000 | 5758000 |
| Thursday, January 1, 2015 | 483393000 | 8423000 |
| Friday, January 1, 2016 | 519270000 | 11986000 |
| Sunday, January 1, 2017 | 567637000 | 15215000 |
| Monday, January 1, 2018 | 601826000 | 15356000 |
| Tuesday, January 1, 2019 | 693218000 | 16660000 |
| Wednesday, January 1, 2020 | 572904000 | 52459000 |
| Friday, January 1, 2021 | 603913000 | 75061000 |
| Saturday, January 1, 2022 | 218108000 | 87221000 |
| Sunday, January 1, 2023 | 253037000 | 83779000 |
| Monday, January 1, 2024 | 245331000 |
Cracking the code
In the competitive world of biopharmaceuticals, understanding cost structures is crucial. This chart compares the cost of revenue for Alkermes plc and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Alkermes consistently reported higher costs, peaking in 2019 with a 47% increase from 2014. However, a significant drop occurred in 2022, with costs plummeting by 63% compared to 2019. In contrast, Supernus Pharmaceuticals, Inc. showed a steady upward trend, with costs rising by over 1,400% from 2014 to 2023. This divergence highlights differing strategies: Alkermes may be optimizing operations, while Supernus is expanding aggressively. Such insights are invaluable for investors and industry analysts seeking to understand the financial dynamics of these companies.
Novo Nordisk A/S vs Alkermes plc: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Alkermes plc
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Exelixis, Inc. vs Alkermes plc
Corcept Therapeutics Incorporated vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc.
Alkermes plc vs Veracyte, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Alkermes plc and BioCryst Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.